Eli Lilly’s stock reached an all-time high of $1022.62 USD, marking a significant milestone for the pharmaceutical giant. According to InvestingPro data, the company’s RSI suggests the stock is in ...
Entered into broad strategic collaboration with Eli Lilly and Company (“Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive ...
Reports Q3 revenue $410,000 vs. $10.9M last year. “Following the close of the third quarter, we are very pleased to have signed a strategic ...
As of September 30, 2025, MeiraGTx (MGTX) had cash and cash equivalents of approximately $14.8 million, as well as $2.8 million in receivables due ...
Lilly will also gain exclusive access to MeiraGTx’s gene therapy platform technologies, including novel intravitreal capsids ...